Masimo Corporation (MASI)
152.10
2.86 (1.92%)
At close: Apr 22, 2025, 3:59 PM
149.86
-1.47%
After-hours: Apr 22, 2025, 06:01 PM EDT
Masimo Revenue Breakdown
| Period Ending | Sep 28, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 |
|---|---|---|---|---|---|---|---|---|
| Health Care Segment Revenue | 343.3M | 339.6M | 339.9M | 307.8M | 281.1M | 346.7M | 351.8M | 327.2M |
| Health Care Segment Revenue Growth | +1.09% | -0.09% | +10.43% | +9.50% | -18.92% | -1.45% | +7.52% | n/a |
Revenue by Geography
| Period Ending | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 | Jan 2, 2021 | Dec 28, 2019 | Dec 29, 2018 | Dec 30, 2017 | Dec 31, 2016 | Jan 2, 2016 | Jan 3, 2015 | Dec 28, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 66.4M | 43.7M | 41.31M | 38.24M | 28.71M | 566.82M | 506.81M | 465.59M | 421.63M | 380.23M | 361.63M |
| Americas Revenue Growth | +51.95% | +5.79% | +8.03% | +33.17% | -94.93% | +11.84% | +8.85% | +10.43% | +10.89% | +5.14% | n/a |
| Asia Pacific Revenue | 351M | 326.8M | 123.59M | 103.76M | 87.96M | n/a | n/a | n/a | n/a | n/a | n/a |
| Asia Pacific Revenue Growth | +7.41% | +164.41% | +19.12% | +17.96% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue | 571.9M | 523.6M | 251.84M | 238.68M | 183.36M | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue Growth | +9.22% | +107.91% | +5.51% | +30.17% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 1.06B | 1.14B | 822.41M | 763.07M | 636.37M | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -7.26% | +38.82% | +7.78% | +19.91% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Jan 2, 2021 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | Jan 2, 2016 | Oct 3, 2015 | Jul 4, 2015 | Apr 4, 2015 | Jan 3, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 184.8M | 177.5M | 159.9M | 159.8M | 156.1M | 151.7M | 196.3M | 185.8M | 174.6M | 188.3M | 108.9M | 104.11M | 100.65M | 93.83M | 96.7M | 90.34M | 90.38M | 98.46M | 89.88M | 81.94M | 80.35M | 78.16M | 74.2M | 74.69M | 72.67M | 71.42M | 71.17M | 78.45M | 65.39M | 66.38M | 65.57M | 69.42M | 57.84M | 63.89M | 62.51M | 70.65M | 59.61M | 61.67M | 60.8M | 61.48M |
| Selling, General, and Administrative Revenue Growth | +4.11% | +11.01% | +0.06% | +2.37% | +2.90% | -22.72% | +5.65% | +6.41% | -7.28% | +72.91% | +4.60% | +3.44% | +7.26% | -2.96% | +7.04% | -0.04% | -8.21% | +9.55% | +9.68% | +1.98% | +2.81% | +5.33% | -0.65% | +2.78% | +1.75% | +0.34% | -9.27% | +19.97% | -1.49% | +1.23% | -5.55% | +20.02% | -9.46% | +2.20% | -11.52% | +18.53% | -3.34% | +1.43% | -1.11% | n/a |
| Research and Development Revenue | 48.3M | 49M | 47.8M | 38M | 46.5M | 40.2M | 50.5M | 54.3M | 53.1M | 47.8M | 36.12M | 33.37M | 35.41M | 33.94M | 34.51M | 31.69M | 28.85M | 30.88M | 27.24M | 23.42M | 24.28M | 24.18M | 21.41M | 19.81M | 19.44M | 19.12M | 18.6M | 16.09M | 15.3M | 15.19M | 15.37M | 14.51M | 15.67M | 14.82M | 14.37M | 13.81M | 14.48M | 13.39M | 14.93M | 15.03M |
| Research and Development Revenue Growth | -1.43% | +2.51% | +25.79% | -18.28% | +15.67% | -20.40% | -7.00% | +2.26% | +11.09% | +32.34% | +8.22% | -5.74% | +4.31% | -1.65% | +8.91% | +9.83% | -6.56% | +13.35% | +16.30% | -3.54% | +0.44% | +12.89% | +8.12% | +1.88% | +1.70% | +2.77% | +15.58% | +5.19% | +0.71% | -1.14% | +5.94% | -7.45% | +5.77% | +3.15% | +4.03% | -4.67% | +8.15% | -10.28% | -0.67% | n/a |